Resources

Resources & News

No Results Found

Try adjusting your search to find what you’re looking for.

BioPharma: Poor buffer lead times and service

Case Studies
Jan 09, 2023
EU-based global animal health biotechnology company with manufacturing operations in the US Midwest was experiencing decreased support from their traditional media hydration and buffer manufacturers due to overall market demand and capacity constraints.

Gene Therapy: CDMO frustrated with service levels

Case Studies
Jan 09, 2023
US-based Gene/ Cell Therapy contract development and manufacturing organization (CDMO) rapidly expanding to address market needs sees customer experience decline due to poor service and long-lead times from their process liquid suppliers.

Cell Therapy: Improved aseptic process

Case Studies
Jan 09, 2023
Southeast Asia-based clinical stage company focused on allogeneic cell therapies for oncology applications was focused on reducing workflow steps and improving their aseptic processes to reduce contamination risk across the workflow.

Life Science Tools: New capabilities for C&GT market

Case Studies
Jan 09, 2023
US-based, > $12B market cap, global raw material and process liquids manufacturer needed scalable cGMP process liquid manufacturing to adequately serve the rapidly growing Cell and Gene Therapy Market.

Research: Lab improves management of FBS

Case Studies
Jan 09, 2023
US-based research laboratory, at a leading cancer research institution, struggled with the variability typically associated with FBS lots from their suppliers, which created risk and extra work for the lab’s personnel as they worked to optimize cell proliferation.

Cell Therapy: Assurance of supply when scaling

Case Studies
Feb 09, 2023
US-based clinical stage Cell Therapy company focused on allogeneic platform needed to secure supply for Yssel’s T-Cell media to confidently meet their manufacturing scale up following positive results from their clinical development process.

Gene Therapy:  Scaling from lab to cGMP

Case Studies
Feb 09, 2023
US-based, pre-clinical stage Gene Therapy innovator scaling products from benchtop to pilot required a nimble liquid manufacturing partner to rapidly manufacture and adjust buffers for process optimization.